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1. Introduction
  Phenolic compounds are secondary plant metabolites that 
constitute one of the most common and widespread groups of 
substances in plants. They are responsible for pigmentation, growth, 
reproduction, and resistance to pathogens. The antibiotic properties 
of phenolic compounds are one of the primary defense mechanisms 
of plants. Most bioactive plant-based antimicrobials are phenol 
derivatives, controlling bacterial growth by altering their membrane 
Objective: To identify and isolate phenolic compounds from Cuspidaria convoluta, and to 
evaluate their antibacterial activity and synergistic effect with antibiotics. 
Methods: The crude extract was prepared by maceration with methanol (5%). The dry extract 
was suspended in water and fractionated successively. The most active extract was selected 
by its antibacterial activity and its total phenol content was determined by spectrophotometry 
and by HPLC-MS/MS. Bioactive fractions of the most active extract were separated 
by column chromatography and evaluated by bioautography. Isolated compounds were 
identified. Minimum inhibitory concentration (MIC) of these compounds was determined 
by microdilution broth method, and synergism with antibiotics (ampicillin, gentamicin and 
oxacillin) was tested by checkerboard and time-kill assays. 
Results: Coumaric acid, catechin/epicatechin, and luteolin were purified and identified 
from the extract. There was an increase in the antibacterial activity of antibiotics when they 
were combined with these compounds. The combination of luteolin and ampicillin had the 
most potent antibacterial activities. The MICs of oxacillin for each of methicillin-resistant 
Staphylococcus aureus strains were reduced between 4 and 8-fold when these strains were 
coincubated with sub-MIC (≤ ½ MIC) levels of these compounds, demonstrating that the 
combination had synergistic effect for all cases. 
Conclusions: Cuspidaria convoluta contains important pharmacologically active substances 
that can be used to improve antibiotic efficacy.
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permeability or reducing the pH. However, their activity is generally 
weak and is often non-specific.
  The combination of natural drugs to treat complex infectious 
diseases is an approach to suppress bacterial resistance that is 
expected to usually develop when a single drug is used[1]. This 
strategy is designed to combine antimicrobial compounds with 
different mechanisms of action for multiple targets. It could 
produce a synergistic antibacterial activity. This approach includes 
combinations of extracts with antimicrobial properties, combinations 
between individual natural products and combinations of extracts 
with antibiotics[2,3]. Over the last decade, the search for synergistic 
interaction between plant extracts and commercial antibiotics 
that have already generated resistance in bacteria has increased 
significantly. Examples include the combination of 毬-lactams with 
毩-mangostin isolated from mangosteen fruit[4] or with quercetin 
or kaempferol from various fruits, vegetables, and grains[5], which 
substantially increased the efficacy of the therapy in 毬-lactam 
resistant bacterial strains. Plant extract/antibiotic combinations not 
only contribute to and enhance the overall antimicrobial effect, 
but can also act as resistance modifying/modulating agents. For 
example, several extracts and essential oils of Salvia spp. and 
Matricaria recutita have been reported to have synergistic effects with 
oxacillin on methicillin resistant Staphylococcus epidermidis, greatly 
improving its efficacy[6]. The results suggest that crude extracts 
from tested plants damage the cytoplasmic membrane and cause 
loss of intracellular components. Therefore, the authors propose 
that observed synergistic effects of plant extracts (essential oils) and 
oxacillin could be theoretically the results of the perturbation of the 
cell membrane coupled with the action of oxacillin.
  Previously,  Torres  et  al [7]  demonstrated ant ioxidant , 
antiinflammatory and antimicrobial activities in the ethanolic extract 
of leaves from Cuspidaria convoluta (C. convoluta). Regarding 
antibacterial effect, this extract was active even against methicillin-
resistant Staphylococcus aureus (S. aureus) (MRSA). 
  The aims of this work were to identify and isolate phenolic 
compounds from C. convoluta, and to evaluate their antibacterial 
activity and synergistic effects with commercial antibiotics.
2. Materials and methods
2.1. Plant material
  The plant was collected in November 2017 in Misiones (Ruta 
Nacional 12 y Santa Ana, 29° 10´39.274´´ S, 58° 51´22.885´´ 
W), Argentina. The plant was identified by specialists from 
the Herbarium of Instituto de Botánica del Nordeste (IBONE-
CONICET), Corrientes, Argentina, where the voucher specimen was 
deposited (AMG 104).
2.2. Extraction 
  Leaves were dried at room temperature until constant weight 
(10.18% humidity percentage). Then, they were triturated until 
particle sizes ranged between 1.70 mm and 710 µm. The crude 
extract was prepared by maceration (25 g) with methanol (500 mL) 
for 24 h using a magnetic stirrer at room temperature. The solvent 
was removed using a rotary evaporator (Buchi, Switzerland). Then, 
a dark green solid was obtained, most of which was suspended in 
water and then fractionated successively by n-hexane and ethyl 
acetate. The hexanic, ethyl acetate and water extracts were obtained 
and evaporated to dryness under vacuum. The extraction yield of 
each extract was 1.4% for hexanic extract, 3.1% for ethyl acetate 
extract and 2.5% for water extract. The dried extracts were stored at 
-20 曟 for further use.
2.3. Selection of extract for isolation of bioactive compounds
  The most active extract was selected by the determination of its 
antibacterial activity. The agar overlay bioautography was used 
according to Nieva Moreno et al[8]. Thin-layer chromatography 
(TLC) plates (Merck, silica gel 60F254 0.2 thickness) were loaded 
with a spot containing 60 µg of each extract (hexanic, ethyl acetate, 
and water extract). Two strains of S. aureus (ATCC 25923 and ATCC 
29213) were used, and were provided by the Laboratory of Clinical 
Analysis of the Hospital Ramón Carrillo, Sáenz Peña, Chaco, 
Argentina. These strains were maintained in brain heart infusion 
(Britania Laboratories, Argentina) containing 30% (v/v) glycerol at 
-20 曟. Plates were incubated for 24 h at 37 曟 and then sprayed with 
thiazolyl blue tetrazolium bromide reagent. Inhibition halos were 
measured. The extract with higher inhibitory effect was used for the 
next assays and its total phenol content was determined according 
to Singleton et al[9]. Besides, the main phenolic compounds of the 
extract were also analyzed by HPLC-MS/MS. The analysis was 
performed in negative mode, and the identification of compounds 
was carried out on the basis of the m/z ratio of the quasimolecular 
ion, fragmentation patterns, data from the literature and/or 
comparison with patterns. Chromatographic separation was achieved 
using ACE 3 C18 analytical column (50 mm 伊 2.1 mm i.d.; 5 µm). 
Mobile phase contained 0.1% of formic acid in water and 0.1% of 
formic acid in acetonitrile at the flow rate of 0.3 mL/min. 
  Separation was carried out under the conditions of gradient elution 
for 30 min. This determination was performed in the Research and 
Development Center in Chemistry of National Institute of Industrial 
Technology, Buenos Aires, Argentina.
2.4. Bioguided fractionation of the extract 
  A portion of the selected extract (10 g) was subjected to column 
chromatography over silica gel (100-200 mesh). Gradient elution of 
increasing polarity was initiated with successive elution using hexane 
(100%), hexane:ethyl acetate (70:30, 50:50 and 30:70), ethyl acetate 
(100%), ethyl acetate:ethanol (70:30, 50:50 and 30:70), ethanol 
(100%), ethanol:methanol (70:30, 50:50 and 30:70), and finally 
only methanol (100%). Fractions having similar TLC profiles were 
pooled to give the major fraction and were stored in a refrigerator 
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and evaluated by bioautography. The fractions that showed the 
presence of halo were subjected to further TLC and bioautographic 
analysis. The mobile phases used were, phase 1: toluene: ethyl 
acetate: glacial acetic acid (36:12:5) and phase 2: ethyl acetate: 
formic acid: glacial acetic acid: water (100:11:11:27). Two plates 
were performed simultaneously. One plate was sprayed with the 
polyethylene glycol reagent for natural products (NP/PEG) which 
was then visualized under visible light and UV at 254 and 365 nm. 
The second plate was used for the bioautography. At the same time, 
different phenolic compounds, such as gallic acid, rutin, quercetin, 
luteolin, and apigenin, were eluted with the different mobile phases 
for comparison with the separated bands in the TLC. The retention 
factor (Rf) values of the bands that showed antimicrobial activity 
were calculated.
2.5. Purification and isolation
  Preparative TLC was performed and developed under conditions 
identical to those described in the previous section. The active bands 
were identified through TLC profiles by comparison with Rf values 
and colors of spots from the TLC previously eluted. These bands 
were scraped off, eluted with methanol and filtered. Subsequently, 
the solvent (methanol) was evaporated from each of the fractions and 
a precipitate was obtained which was dissolved in methanol (HPLC 
grade) and purity analysis was made by HPLC-DAD. The pure 
compounds were obtained. 
2.6. Identification of isolated compounds from fractions
  The compounds were tentatively identified by comparison of 
retention times and their UV-VIS spectra from 200 to 400 nm, as 
well as by the addition of an external standard. HPLC-MS/MS and 
IR spectroscopy confirmed the identity of the compounds. 
2.7. Determination of antibacterial activity of the isolated 
compounds 
2.7.1. Microorganisms
  A total of 12 clinical isolates of ampicillin-resistant S. aureus, of 
which 3 were MRSA and gentamicin resistant (Sa 5307, Sa 5637, 
and Sa 5722) were used. In addition, Gram-negative bacteria such as 
Escherichia coli (E. coli) ATCC 35218, Pseudomonas aeruginosa (P. 
aeruginosa) ATCC 27853 and multiresistant clinical isolates of E. 
coli and P. aeruginosa were used. These strains were obtained from 
patients hospitalized at the Hospital Ramón Carrillo, Sáenz Peña, 
Argentina. Inocula were prepared by adjusting the turbidity of the 
suspension to match the 0.5 McFarland standards.
2.7.2. Determination of minimum inhibitory concentrations 
(MICs)
  MIC values of the isolated compounds and antibiotic (ampicillin, 
gentamicin, and oxacillin) against the tested microorganisms were 
determined by the broth microdilution method[10]. All compounds 
were dissolved in dimethyl sulfoxide (DMSO) and two-fold serial 
dilutions were prepared. The concentration of DMSO used in the 
assay was 2.9%. Then, 3 µL of these dilutions and 100 µL inoculum 
(~5 伊 105 CFU/mL) were added to each well. Growth control 
well contained bacterial cells and 3 µL of DMSO without any 
test compound, and sterile control only had growth medium. The 
concentrations tested for the compounds were 1 600, 800, 400, 200, 
100, 50 and 25 µg/mL. Plates were aerobically incubated at 37 曟 for 
16-20 h. Bacterial growth was indicated by the presence of turbidity 
and/or a pellet on the well bottom. The assays were performed in 
triplicate and as independent tests; and mean values were calculated. 
2.7.3. Determination of synergistic activity between natural 
compounds and commercial antibiotics 
  The synergy between compounds and selected antibiotics 
(ampicillin, gentamicin and oxacillin only for MRSA strains) was 
studied by the checkerboard assay method[11]. With the exception 
of ATCC strains, all bacteria mentioned in section 2.7.1 were used 
in this assay. The combinations were transferred to each microplate 
well. The concentrations used in the combinations for each antibiotic 
ranged from 0.19 to 1 600 µg/mL and for each natural compound 
between 6.25 and 1 600 µg/mL. MIC values were determined for 
each antibiotic and for each of these combinations. The bacterial 
growth and sterile controls were prepared. The fractional inhibitory 
concentration (FIC) was calculated as follows:
FICatb = MICatb in combination with nc/MICatb (1)
FICnc = MICnc in combination with atb/MICnc (2)
Where MICatb is MIC of antibiotics whereas MICnc MIC of natural 
compounds.
  Then, the FIC Index (FICI) was calculated according to the 
following equation (3):
FICI = FICatb + FICnc (3)
  According to Schelz et al[12] the FICI values were interpreted as 
either synergistic (≤0.5), additive (>0.5 and ≤1), indifferent (>1 and 
<4) or antagonistic (≥4). 
  For each combination producing synergistic interactions, 6-7 
different ratios were tested. All combinations were tested in 
duplicates in three independent experiments, providing 6 replicates 
for each combination ratio. Data were presented as the mean of 
6 replicates. Data for each ratio examined were plotted on an 
isobologram, and this was used to determine optimal combination 
ratios to obtain synergy.
  Time-kill assays were only performed against the bacteria most 
resistant to antibiotics according to Petersen et al[13]. Bacterial 
suspensions with appropriate dilution to ~ 1伊105 - 1伊106 CFU/mL 
of each bacterium in broth media were pre-incubated at 37 曟. These 
samples were co-incubated with natural compounds or antibiotic 
adjusted to a series of final concentration of 1/2伊MIC, 1伊MIC, and 
2伊MIC, with the addition of broth media. Simultaneously, a growth 
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control without natural compounds/antibiotic was also subjected to this 
test. In order to count viable cells (CFU), aliquots of 100 µL were taken 
from the culture before (0 h, positive control) and after (4, 8, 12 and 
24 h) the addition of the drugs using spread plate technique. During 
the experiment, the mixture was maintained at 37 曟. In addition, the 
natural compound and the antibiotic, with a series of equal ratio dilution 
from 1/4伊MIC to 1/2伊MIC, were combined to explore the combination 
kill-time according to the same procedure. Three plates were used for 
each sample. Synergism was demonstrated when there was a reduction 
of ≥2 log CFU/mL of the original inoculum[14].
3. Results 
3.1. Identification and isolation of phenolic compounds from 
C. convoluta leaves
3.1.1. Selection of extract for isolation of bioactive compounds 
  The ethyl acetate extract was the most active extract in the 
bioautography with inhibition halos larger than 10 mm [(16 ± 1) mm]. 
Hexanic extract did not show any activity, while the water extract 
showed inhibition halos of (12.0 ± 0.5) mm. The total phenol content 
of ethyl acetate extract was (32.27 ± 0.93) mg GAE/g of dry extract. 
The presence of seven polyphenolic compounds was demonstrated 
by HPLC-ESI-MS/MS. The phenol compounds identified were 
coumaric acid derivative, caffeic acid derivative, coumaric acid, 
catechin/epicatechin, luteolin, hydroxybenzoic acid sugar derivative 
and cirsiliol. 
3.1.2. Bioguided fractionation of the extract 
  A total of 70 fractions were obtained by column chromatography, of 
which 6 had antibacterial activity in the bioautographic assay. These 
fractions demonstrated the presence of more than one compound 
responsible for the activity. However, only three compounds could 
be isolated and purified of these fractions by preparative TLC (Data 
were not shown).
3.1.3. Purification, isolation and identification of bioactive 
compounds
  Compound 1 (C1) was obtained as compact powder and showed 
UV absorption at about 345 nm. Its mass spectrum showed a 
molecular ion and base peak at 165 m/z with other significant peaks 
at 119. The compound was identified as coumaric acid with the 
injection of a solution of the pure standards, which matched the 
feature in both retention time and fragmentation pattern, including 
an additional fragment at m/z 93.034. The chemical formula of C1 
was C9H8O3. As p-coumaric acid is the most abundant form, the 
identification was attributed to the para isomer. In addition, the 
IR spectrum exhibited peaks at 3 385 cm-1 (carboxylic acid O-H 
stretching), 1 674 and 1 690 cm-1 (carboxylic acid C=O stretching), 
1 248 cm-1 (carboxylic acid C-O stretching) and 1 510; 1 629 cm-1 
(aromatic C=C).
  Compound 2 (C2) was obtained as amorphous yellow solid. C2 
showed a molecular ion peak at m/z 289 and an ion fragment at m/z 
245. The presence of this fragment may be caused by a neutral loss 
of CO2. C2 showed a UV spectrum with two maximum of absorption 
at 239 nm and 280 nm. These features were characteristic of 
catechins. The enantioseparation of catechin and epicatechin could 
not be performed so C2 could be catechin or its epimer epicatechin, 
both with molecular formula C15H14O6. The IR spectrum showed the 
characteristic absorption regions for O-H group (3 400 – 3 100 cm-1), 
C = C group around 1 600 cm-1, as well as C – O group (1 150 – 
1 010 cm-1). 
  Compound 3 (C3) was obtained as a yellow needle which showed 
a molecular ion peak at m/z 285, and fragmentation patterns at 
241, 199, 175. In addition, similar to compound 1, a solution of 
the pure standard luteolin was injected and the retention times and 
fragmentation patterns were coincident with C3. The molecular 
Table 1. MIC values of isolated compounds from Cuspidaria convoluta extract and antibiotics on pathogenic bacteria.
Strains p-Coumaric acid Catechin/epicatechin Luteolin   Ampicillin   Gentamicin  Oxacillin
S. aureus ATCC 25923  100   400 100     0.19    0.78    0.39
S. aureus ATCC 29213  100   400 100     0.78    0.78    0.39
S. aureus 5357  100   800 200     3.12    1.56    0.78
S. aureus 5289  100   800 200     6.25    3.12    0.78
S. aureus 5632    50   400 200     6.25    3.12    1.56
S. aureus 5627   400   400 400     3.12    6.25    0.78
S. aureus 5377   100   400 800     6.25    6.25    1.56
S. aureus 5621   200   400 400     1.56    3.12    1.56
S. aureus 5246   100   800 400     3.12    3.12    1.56
S. aureus 5307#   800   800 400   12.50  12.50   25.00
S. aureus 5637#   400   800 400   50.00   50.00   50.00
S. aureus 5722#   400   800 400   50.00   50.00 100.00
E. coli ATCC 35218   800 1 600 400 400.00 400.00
E. coliλ   400 1 600 400 400.00 400.00
P. aeruginosa ATCC 27853 1 600 1 600 800 400.00 400.00
P. aeruginosaλ 1 600 1 600 800 800.00 800.00
Values expressed in µg/mL. # resitant to methicillin and gentamicin, λresistant to ampicillin and gentamicin.
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Table 2. Interactions of phenolic compounds with ampicillin (A) and gentamicin (G) against pathogenic bacteria.

















































































































































1MIC values expressed as antibiotic concentration/phenolic compound concentration in the combination (µg/mL) against each bacterial strain. 2FICI values of 
different combinations between brackets. FICI: Fractional inhibitory concentration index: calculated as mentioned in methods. aSynergism (≤ 0.5), bAdditivity (> 
0.5 and ≤ 1). Sa: S. aureus; Ec: E. coli; Pa: P. aeruginosa. CA: coumaric acid, C: catechin/epicatechin, L: luteolin.
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Figure 1. Isobolograms of the combinations of luteolin and ampicillin against resistant bacteria: A) S. aureus 5307, B) S. aureus 5637, C) S. aureus 5722, D) 
ampicillin resistant E. coli and E) ampicillin resistant P. aeruginosa. 
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formula of C3 was C15H10O6, corresponding to luteolin. The IR 
spectra showed absorption bands for hydroxyl groups (3 405 cm-1), 
aromatic ring (1 441 cm-1), carbonyl group (1 655 cm-1) and hydroxyl 
aromatic (1 370 cm-1).
3.2. Antibacterial activity of the isolated compounds and their 
synergistic action with antibiotics
3.2.1. MICs of the isolated compounds 
  The MIC values of all compounds are shown in Table 1. The results 
demonstrated that all compounds were active in the bioautographic 
tests, and exhibited antibacterial activity against all Gram-positive 
strains in concentrations of 50-800 µg/mL, even against MRSA 
(Sa 5307, 5637, and 5722). Moreover, these phytochemicals had 
moderate to weak antibacterial activities against different Gram-
negative bacteria such as E. coli (400-1 600 µg/mL), and P. 
aeruginosa (800-1 600 µg/mL) strains. 
3.2.2. Synergistic activity between natural compounds and 
commercial antibiotics 
  With respect to the synergistic effect of these compounds combined 
with ampicillin and gentamicin, the results are shown in Table 2. In 
most of these combinations, the FICI exhibited either a synergistic 
or an additive effect. A strong synergistic interaction was recorded 
against most of the bacteria with the combination of ampicillin and 
luteolin (FICI values between 0.08 and 0.50). Isobolograms also 
confirm the interaction between this antibiotic and luteolin (Figure 
1). All graphs showed concave curves, which is characteristic of 
synergism between compounds (FICI ≤ 0.5). The combination 
of antibiotics with all the tested compounds led to an enhanced 
antimicrobial effect against S. aureus strains even up to 16 times the 
MIC. 
  The MIC values of ampicillin and gentamicin were 4-8 times lower 
when both were used in combination with these phenolic compounds 
against E. coli. Notably, the combination of ampicillin with the 
three compounds even showed activity against P. aeruginosa with a 
reduction in the MIC of the antibiotic which was between 8-64 times 
lower. 
  Based on the time-kill results, all the combinations showed 
synergism. However, the combination of luteolin with ampicillin 
was the most relevant. In this case, the synergistic effect against 
ampicillin-resistant E. coli and P. aeruginosa strains appeared after 
8 h while in the others (coumaric acid and catechin/epicatechin 
combined with ampicillin and combinations with gentamicin) 
it appeared only after 12 hours of the trial (data are not shown). 
Moreover, a bactericidal effect of luteolin/ampicillin was shown 
at the end of the test (Figure 2). There was sustained synergistic 
inhibitory activity lasting for more than 24 h; bacterial colony counts 
were reduced by 2 log CFU/mL when compared with ampicillin 
alone. 
  Table 3 and Figure 3 show the synergistic effects of combining 
these polyphenols with oxacillin for each MRSA strain. This 
combination decreased the MIC of the antibiotic for each isolate. 
The MIC of oxacillin decreased by 4-8-fold for MRSA strains. 
These results demonstrated that the compounds were synergistic 
with oxacillin for each of the three MRSA strains tested in the 
plotted isobolograms (Figure 4). Figure 3 shows that the potency 
of the combined agents was more significant than individual ones; 
the reduction in colony count was ≥ 2 log CFU/mL over the first 12 
hours of trial when the combination of luteolin and oxacillin was 
used. 
Table 3. Interactions of phenolic compounds with oxacillin (O) against 
MRSA.



















1MIC values expressed as antibiotic concentration/phenolic compound 
concentration in the combination (µg/mL) against each bacterial strain. 
2FICI values of different combinations between brackets. FICI: Fractional 
inhibitory concentration index: calculated as mentioned in the method part. 
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Figure 2. Time kill curves and synergistic effect of luteolin-ampicillin combination against A) ampicillin resistant E. coli and B) ampicillin resistant P. 
aeruginosa. Control strain (剃), 2 MIC luteolin (茺), 2 MIC ampicillin (剃), MIC luteolin (書), MIC ampicillin (●), ½ MIC luteolin (●), ½ MIC ampicillin (●), 
combination ½ MIC luteolin and ½ MIC ampicillin (♦茺), combination ¼ MIC luteolin and ¼ MIC ampicillin (●).
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Figure 3. Time kill curves and synergistic effect of luteolin-oxacillin combination against MRSA strains, A) S. aureus 5307, B) S. aureus 5637 and C) S. 
aureus 5722. Control strain (剃), 2 MIC luteolin (剃), 2 MIC oxacillin (剃), MIC luteolin (書), MIC oxacillin (●), ½ MIC luteolin (●), ½ MIC oxacillin (●), 
combination ½ MIC luteolin and ½ MIC oxacillin (茺), combination ¼ MIC luteolin and ¼ MIC oxacillin (剃).
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Figure 4. Isobolograms of the combinations of phenolic compounds with oxacillin against MRSA strains. A) coumaric acid-oxacillin against S. aureus 5307, 
B) catechin/epicatechin-oxacillin against S. aureus 5307, C) luteolin-oxacillin against S. aureus 5307, D) coumaric acid-oxacillin against S. aureus 5637, 
E) catechin/epicatechin-oxacillin against S. aureus 5637, F) luteolin-oxacillin against S. aureus 5637, G) coumaric acid-oxacillin against S. aureus 5722, H) 
catechin/epicatechin-oxacillin against S. aureus 5722 and I) luteolin-oxacillin against S. aureus 5722.
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4. Discussion
  Regarding the phytochemical composition of C. convoluta, Torres 
et al[7] reported the presence of a coumaric acid derivative, luteolin, 
hydroxybenzoic acid sugar derivative, and cirsiliol in its ethanolic 
extract. In the present work, catechin/epicatechin, luteolin, and 
p-coumaric acid could be isolated and identified. Regarding coumaric 
acid, its presence has already been reported in other representatives 
of Bignoniaceae family even in the Cuspidaria genus[15,16]. It is 
also found in C. convoluta in this study. Concerning catechins, their 
presence in the genus Cuspidaria has not yet been reported.
  In relation to the antimicrobial activity, the results of present study 
suggest that MIC values close to 100 µg/mL could be considered 
noteworthy[17]. Therefore, p-coumaric acid would be the most active 
isolated compound with MIC values of 50 and 100 µg/mL against 
seven S. aureus strains. These results are in agreement with those of 
Lou et al[18] and Orhan et al[19], who reported antimicrobial activity 
of p-coumaric acid against S. aureus. However, the MIC value needed 
to inhibit the growth of MRSA (MIC= 1 000 µg/mL) was higher 
than that found in this work (MIC= 400-800 µg/mL), and the authors 
informed that no inhibitory effect was found against methicillin 
sensible S. aureus[20]. On the other hand, MIC values found in this 
work for p-coumaric acid were higher than those reported in other 
paper for E. coli (MIC=80 µg/mL)[18]. This difference is probably 
due to the different sensitivity of the clinical strains used. 
  The results of the synergism tests showed that the best combination 
was ampicillin with luteolin. These were to be expected since, 
in previous work, the combination of C. convoluta extract and 
ampicillin even showed activity against P. aeruginosa (strains Pa 
and F305) with a reduction in 16 times the MIC of the antibiotic[21]. 
Several works showed that luteolin increases the efficacy of different 
antibiotics, since it inhibits 毬-lactamase in multidrug-resistant 
E. coli strains[22], affects the cytoplasmic membrane stability; and 
inhibits enzymes involved in the synthesis of folic acid[2]. This could 
explain the results obtained with the combination of luteolin and 
ampicillin in this work.
  In addition, our results support the findings of Hemaiswarya and 
Doble[23], who previously demonstrated the ability of p-coumaric 
acid to enhance the effect of commercial antibiotics against Gram-
negative and Gram-positive bacteria. 
  As mentioned above, the phenolic compounds can act 
synergistically with different classes of antibiotics by several 
mechanisms[22,24-26]. Concerning the synergistic effect in the 
luteolin/oxacillin combination against MRSA strains, Joung et al[27] 
have demonstrated the potential of luteolin as an active therapeutic 
agent against MRSA, reinforcing the possibility of substantially 
reducing the use of existing antibiotics. 
  In conclusion, p-coumaric acid, catechin/epicatechin, and luteolin 
were isolated from C. convoluta leaves and identified. Although these 
compounds are present in most plants, they have not been isolated 
from C. convoluta and studied yet. This contributes to the knowledge 
of this species, which until now, has been scarcely studied from the 
phytochemical perspective. 
  There is a synergistic interaction between the phenolic compounds 
isolated from C. convoluta and selected antibiotics. The synergy 
observed allows reducing the dose of antibiotics which translates 
into a decrease in the adverse effects associated with the use of these 
drugs. In addition, the mentioned compounds could be a solution 
for the multidrug resistance problem, but their mechanism of action 
in different microorganisms should be better understood and further 
explored, which will allow more effective and safer treatments to be 
developed than the current ones. 
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